Dennis Merkle PhD, EMBA

Dennis Merkle has been appointed as CEO of Predicine Europe and as the company's global head of biopharma business. He comes to Predicine from Invitae, where he led the oncology development strategy, alliance management, and biorepository teams. He joined Invitae as part of its acquisition of ArcherDx, where he was senior VP of corporate development. Prior to that, he built the global companion diagnostics group at Merck KGaA and held senior positions in marketing and R&D at Merck KGaA, Abbott Laboratories, and Philips.